# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0000899923-21-000007
Filing Date
2021-02-23
Accepted
2021-02-23 16:15:16
Documents
38
Period of Report
2021-02-22
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | mygn-20210222.htm iXBRL | 8-K | 57760
2 | EX-10.1 | mygn-x1231earningsreleasex.htm | EX-10.1 | 1257835
3 | EX-99.1 | mygn-x1231earningsreleasexa.htm | EX-99.1 | 433095
4 | EX-99.2 | earningsslidesfinal.htm | EX-99.2 | 18509
10 | GRAPHIC | earningsslidesfinal001.jpg | GRAPHIC | 75932
11 | GRAPHIC | earningsslidesfinal002.jpg | GRAPHIC | 172252
12 | GRAPHIC | earningsslidesfinal003.jpg | GRAPHIC | 121356
13 | GRAPHIC | earningsslidesfinal004.jpg | GRAPHIC | 92106
14 | GRAPHIC | earningsslidesfinal005.jpg | GRAPHIC | 95451
15 | GRAPHIC | earningsslidesfinal006.jpg | GRAPHIC | 100413
16 | GRAPHIC | earningsslidesfinal007.jpg | GRAPHIC | 116453
17 | GRAPHIC | earningsslidesfinal008.jpg | GRAPHIC | 96084
18 | GRAPHIC | earningsslidesfinal009.jpg | GRAPHIC | 173250
19 | GRAPHIC | earningsslidesfinal010.jpg | GRAPHIC | 80156
20 | GRAPHIC | earningsslidesfinal011.jpg | GRAPHIC | 99164
21 | GRAPHIC | earningsslidesfinal012.jpg | GRAPHIC | 100171
22 | GRAPHIC | earningsslidesfinal013.jpg | GRAPHIC | 96455
23 | GRAPHIC | earningsslidesfinal014.jpg | GRAPHIC | 86727
24 | GRAPHIC | earningsslidesfinal015.jpg | GRAPHIC | 94347
25 | GRAPHIC | earningsslidesfinal016.jpg | GRAPHIC | 100141
26 | GRAPHIC | earningsslidesfinal017.jpg | GRAPHIC | 118459
27 | GRAPHIC | earningsslidesfinal018.jpg | GRAPHIC | 109366
28 | GRAPHIC | earningsslidesfinal019.jpg | GRAPHIC | 76159
29 |  | image_01.jpg | GRAPHIC | 2354
30 |  | image_21.jpg | GRAPHIC | 1562
| Complete submission text file | 0000899923-21-000007.txt |  | 4902444

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | mygn-20210222.xsd | EX-101.SCH | 2405
6 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | mygn-20210222_cal.xml | EX-101.CAL | 698
7 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | mygn-20210222_def.xml | EX-101.DEF | 1631
8 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | mygn-20210222_lab.xml | EX-101.LAB | 23970
9 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | mygn-20210222_pre.xml | EX-101.PRE | 12634
31 | EXTRACTED XBRL INSTANCE DOCUMENT | mygn-20210222_htm.xml | XML | 10768

Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108 801-584-3600
MYRIAD GENETICS INC (Filer) CIK: 0000899923 (see all company filings)

EIN.: 870494517 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 000-26642 | Film No.: 21665551
SIC: 2835 In Vitro & In Vivo Diagnostic Substances